Novel weak D types 31 and 32:: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types

被引:32
作者
Körmöczi, GF
Förstemann, E
Gabriel, C
Mayr, WR
Schönitzer, D
Gassner, C
机构
[1] Univ Vienna, Dept Blood Grp Serol & Transfus Med, A-1090 Vienna, Austria
[2] Red Cross Blood Donor Serv Sachsen, Inst Transfus Med, Dresden, Germany
[3] Red Cross Transfus Serv Upper Austria, Linz, Austria
[4] Gen Hosp, Cent Inst Blood Transfus, Innsbruck, Austria
[5] Gen Hosp, Dept Immunol, Innsbruck, Austria
[6] Univ Clin Innsbruck, Innsbruck, Austria
关键词
D O I
10.1111/j.1537-2995.2005.00580.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Weak D types are thought to express rather quantitative than qualitative D antigen variants. Distinct type-specific phenotypes and weak D cases with anti-D alloimmunization, however, suggest a variable degree of D antigen alteration. Study Design and Methods: Variant D types were investigated by use of molecular typing, RHD sequencing, extended serologic D antigen investigations, and flow cytometric D antigen density determination. Results: Two novel weak D types were discovered, termed weak D type 31 and 32 with single RHD nucleotide substitutions coding for amino acid exchanges in predicted intracellular RhD polypeptide stretches, with antigen densities of approximately 130 and 50 D sites per red blood cell, respectively. Adsorption-elution technique-supported D epitope mapping of these two weak D types, the recently described weak D type 26, and of the most common Central European weak D types (weak D types 1, 2, 3, 4.0, and 4.1) demonstrated the expression of all tested D epitopes. In contrast, a distinct D epitope loss was detected in weak D type 15 and partial D control samples. Conclusion: All novel and prevalent weak D types expressed all tested D epitopes. Our results indicate that adsorption-elution techniques may be of advantage whenever D epitope loss is suspected in extremely weak D variants.
引用
收藏
页码:1574 / 1580
页数:7
相关论文
共 28 条
[1]   The Rh blood group system: a review [J].
Avent, ND ;
Reid, ME .
BLOOD, 2000, 95 (02) :375-387
[2]   Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype [J].
Beckers, EAM ;
Faas, BHW ;
Ligthart, P ;
Simsek, S ;
Overbeeke, MAM ;
vondemBorne, AEGK ;
vanRhenen, DJ ;
vanderSchoot, CE .
TRANSFUSION, 1996, 36 (06) :567-574
[3]   SEROTYPE SWITCHING IN A PARTIALLY DELETED RHD GENE [J].
BLUNT, T ;
DANIELS, G ;
CARRITT, B .
VOX SANGUINIS, 1994, 67 (04) :397-401
[4]   Fatal hydrops fetalis caused by anti-D in a mother with partial D [J].
Cannon, M ;
Pierce, R ;
Taber, EB ;
Schucker, A .
OBSTETRICS AND GYNECOLOGY, 2003, 102 (05) :1143-1145
[5]  
Daniels G., 2002, HUMAN BLOOD GROUPS
[6]   RHD antigen density and agglutination in RHD variant red cells [J].
Flegel, WA ;
Wagner, FF .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1996, 3 (06) :385-386
[7]   Section 1B:: Rh flow cytometry -: Coordinator's report.: Rhesus index and antigen density:: an analysis of the reproducibility of flow cytometric determination [J].
Flegel, WA ;
Curin-Serbec, V ;
Delamaire, M ;
Donvito, B ;
Ikeda, H ;
Jorgensen, J ;
Kumpel, B ;
Le Pennec, PY ;
Písacka, M ;
Tani, Y ;
Uchikawa, M ;
Wendel, S ;
Wagner, FF .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2002, 9 (01) :33-42
[8]   Presence of RHD in serologically D-, C/E+ individuals:: a European multicenter study [J].
Gassner, C ;
Doescher, A ;
Drnovsek, TD ;
Rozman, P ;
Eicher, NI ;
Legler, TJ ;
Lukin, S ;
Garritsen, H ;
Kleinrath, T ;
Egger, B ;
Ehling, R ;
Körmöczi, GF ;
Kilga-Nogler, S ;
Schoenitzer, D ;
Petershofen, EK .
TRANSFUSION, 2005, 45 (04) :527-538
[9]   RHD/CE typing by polymerase chain reaction using sequence-specific primers [J].
Gassner, C ;
Schmarda, A ;
KilgaNogler, S ;
JennyFeldkircher, B ;
Rainer, E ;
Muller, TH ;
Wagner, FF ;
Flegel, WA ;
Schonitzer, D .
TRANSFUSION, 1997, 37 (10) :1020-1026
[10]   HEMOLYTIC DISEASE OF NEWBORN DUE TO ANTI-D ANTIBODIES IN A DU-POSITIVE MOTHER [J].
HILL, Z ;
VACL, J ;
KALASOVA, E ;
CALABKOVA, M ;
PINTERA, J .
VOX SANGUINIS, 1974, 27 (01) :92-94